☰

Richard Albin - Publications

Affiliations: 
Department of Special Education and Clinical Sciences University of Oregon, Eugene, OR, United States 
Area:
Special Education, Occupational Therapy
Tree Info Similar researchers PubMed Report error

6/443 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement. Neuropsychological Rehabilitation. 1-15. PMID 27499422 DOI: 10.1080/09602011.2016.1190533  0.35
2016 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement. Physical Therapy. 96: e1-e10. PMID 27371692 DOI: 10.2522/Ptj.2016.96.7.E1  0.34
2016 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement. The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association. 70: 7004320010p1-7004320. PMID 27294998 DOI: 10.5014/Ajot.2016.704002  0.332
2016 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. The Single-Case Reporting guideline In BEhavioural interventions (SCRIBE) 2016 statement. Journal of School Psychology. 56: 133-142. PMID 27268573 DOI: 10.1016/J.Jsp.2016.04.001  0.34
2016 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 statement: Énoncé concernant la Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016. Canadian Journal of Occupational Therapy. Revue Canadienne D'ErgothéRapie. 83: 184-95. PMID 27231387 DOI: 10.1177/0008417416648124  0.351
2016 Tate RL, Rosenkoetter U, Vohra S, Horner R, Kratochwill T, Sampson M, Togher L, Backman C, Evans JJ, Manolov R, Nickels L, Ownsworth T, Schmid CH, Perdices M, Shadish W, ... ... Albin R, et al. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement. Journal of Clinical Epidemiology. PMID 27101888 DOI: 10.1037/Arc0000026  0.34
Low-probability matches (unlikely to be authored by this person)
2012 Powell LE, Glang A, Ettel D, Todis B, Sohlberg MM, Albin R. Systematic instruction for individuals with acquired brain injury: results of a randomised controlled trial. Neuropsychological Rehabilitation. 22: 85-112. PMID 22264146 DOI: 10.1080/09602011.2011.640466  0.289
2019 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. Normes de présentation de recherche utilisant les protocoles à cas unique en interventions comportementales (SCRIBE-2016) Pratiques Psychologiques. 25: 103-117. DOI: 10.1016/J.Prps.2018.11.001  0.286
2011 Lemoncello R, Sohlberg MM, Fickas S, Albin R, Harn BE. Phase I evaluation of the television assisted prompting system to increase completion of home exercises among stroke survivors. Disability and Rehabilitation. Assistive Technology. 6: 440-52. PMID 21171844 DOI: 10.3109/17483107.2010.542571  0.267
2017 Cho YS, Sohlberg MM, Albin R, Diller L, Horner R, Rath J, Bullis M. Training adults with acquired brain injury how to help-seek when wayfinding: an understudied critical life skill. Neuropsychological Rehabilitation. 1-18. PMID 28697674 DOI: 10.1080/09602011.2017.1344131  0.263
2015 Ehlhardt Powell L, Glang A, Pinkelman S, Albin R, Harwick R, Ettel D, Wild M. Systematic instruction of assistive technology for cognition (ATC) in an employment setting following acquired brain injury: A single case, experimental study. Neurorehabilitation. PMID 26518534 DOI: 10.3233/Nre-151272  0.262
2016 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement. Aphasiology. 30: 862-876. PMID 27279674 DOI: 10.1080/02687038.2016.1178022  0.244
2005 Ehlhardt LA, Sohlberg MM, Glang A, Albin R. TEACH-M: A pilot study evaluating an instructional sequence for persons with impaired memory and executive functions. Brain Injury. 19: 569-83. PMID 16175811 DOI: 10.1080/002699050400013550  0.237
2016 Tate RL, Perdices M, Rosenkoetter U, Shadish W, Vohra S, Barlow DH, Horner R, Kazdin A, Kratochwill T, McDonald S, Sampson M, Shamseer L, Togher L, Albin R, Backman C, et al. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement. Evidence-Based Communication Assessment and Intervention. 10: 44-58. PMID 27499802 DOI: 10.1080/17489539.2016.1190525  0.236
2014 Albin RL, Dauer WT. Magic shotgun for Parkinson's disease? Brain : a Journal of Neurology. 137: 1274-5. PMID 24771397 DOI: 10.1093/brain/awu076  0.179
2013 Antonini A, Albin R. Author Response Neurology. 81: 854-855. PMID 24137728 DOI: 10.1212/WNL.0b013e3182a39431  0.171
2014 Pappas SS, Leventhal DK, Albin RL, Dauer WT. Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits. Current Topics in Developmental Biology. 109: 97-169. PMID 24947237 DOI: 10.1016/B978-0-12-397920-9.00001-9  0.164
2018 Lieberman AP, Shakkottai VG, Albin RL. Polyglutamine Repeats in Neurodegenerative Diseases. Annual Review of Pathology. PMID 30089230 DOI: 10.1146/Annurev-Pathmechdis-012418-012857  0.163
2009 Bohnen NI, Albin RL. Cholinergic denervation occurs early in Parkinson disease. Neurology. 73: 256-7. PMID 19535769 DOI: 10.1212/WNL.0b013e3181b0bd3d  0.162
2011 Tallaksen-Greene SJ, Albin RL. Treating mouse models of Huntington disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2373-4. PMID 21814186 DOI: 10.1038/npp.2011.158  0.16
2011 Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behavioural Brain Research. 221: 564-73. PMID 20060022 DOI: 10.1016/j.bbr.2009.12.048  0.159
2015 Müller ML, Albin RL, Bohnen NI, Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study. Neurology. 84: 2292. PMID 26033339 DOI: 10.1212/Wnl.0000000000001654  0.159
2015 Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA. Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 928-35. PMID 25879534 DOI: 10.1002/Mds.26191  0.156
2012 Albin RL, Dauer WT. Parkinson syndrome. Heterogeneity of etiology; heterogeneity of pathogenesis? Neurology. 79: 202-3. PMID 22722622 DOI: 10.1212/WNL.0b013e31825dd3d0  0.155
2010 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain : a Journal of Neurology. 133: 1747-54. PMID 20413575 DOI: 10.1093/Brain/Awq079  0.155
2001 Albin RL. End of lines and boxes. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 405-6. PMID 11391733 DOI: 10.1002/mds.1086  0.155
2011 Bohnen NI, Albin RL. White matter lesions in Parkinson disease. Nature Reviews. Neurology. 7: 229-36. PMID 21343896 DOI: 10.1038/nrneurol.2011.21  0.152
2014 Albin RL. Nourish the roots while picking the fruit. Neurology. 83: 1473-5. PMID 25313377 DOI: 10.1212/01.wnl.0000455934.19444.86  0.151
2008 Albin RL. Comment on Eskenazi et al. Medical Hypotheses. 71: 151-2. PMID 18329820 DOI: 10.1016/j.mehy.2008.01.022  0.151
2017 Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB, Foroud T, German D, Huang X, et al. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomarkers in Medicine. PMID 28644039 DOI: 10.2217/Bmm-2016-0370  0.151
2012 Petrou M, Bohnen NI, Müller ML, Koeppe RA, Albin RL, Frey KA. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. 79: 1161-7. PMID 22933741 DOI: 10.1212/Wnl.0B013E3182698D4A  0.149
2006 Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends in Neurosciences. 29: 175-82. PMID 16430974 DOI: 10.1016/J.Tins.2006.01.001  0.149
2013 Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain : a Journal of Neurology. 136: 3282-9. PMID 24056537 DOI: 10.1093/Brain/Awt247  0.148
2008 Mauldin PD, Guimaraes P, Albin RL, Ray Dorsey E, Bainbridge JL, Siderowf A. Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy. Clinical Therapeutics. 30: 1553-7. PMID 18803996 DOI: 10.1016/j.clinthera.2008.08.001  0.147
2005 Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.Wnl.0000149403.14458.7F  0.145
2019 Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM. Cholinergic system changes of falls and freezing of gait in Parkinson disease. Annals of Neurology. PMID 30720884 DOI: 10.1002/Ana.25430  0.143
2018 Albin RL, Surmeier DJ, Tubert C, Sarter M, Müller MLTM, Bohnen NI, Dauer WT. Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30398673 DOI: 10.1002/mds.27540  0.143
2015 Dayalu P, Albin RL. Huntington disease: pathogenesis and treatment. Neurologic Clinics. 33: 101-14. PMID 25432725 DOI: 10.1016/j.ncl.2014.09.003  0.143
1996 Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of Neurology. 40: 873-84. PMID 9007092 DOI: 10.1002/Ana.410400609  0.143
2014 Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, Scott PJ, Albin RL, Müller ML. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1118-24. PMID 24909584 DOI: 10.1002/Mds.25929  0.142
2007 Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL. Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8989-98. PMID 17715336 DOI: 10.1523/Jneurosci.1830-07.2007  0.141
2010 Bohnen NI, Müller MLTM, Kotagal V, Koeppe RA, Kilbourn MR, Albin RL, Frey KA. Reply: Cognition and olfaction in Parkinson's disease Brain. 133: e161. DOI: 10.1093/Brain/Awq228  0.141
2006 Albin RL. Practice Parameters for Parkinson disease: signposts for clinical research. Neurology. 66: 966-7. PMID 16606906 DOI: 10.1212/01.wnl.0000214662.19840.ea  0.14
2018 Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, ... ... Albin RL, et al. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer's disease target. Brain : a Journal of Neurology. PMID 30137212 DOI: 10.1093/Brain/Awy215  0.139
2007 Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, ... ... Albin R, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.Wnl.0000250355.28474.8E  0.139
1990 Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. The New England Journal of Medicine. 322: 1293-8. PMID 1691447 DOI: 10.1056/Nejm199005033221807  0.139
2011 Bohnen NI, Albin RL, Müller ML, Chou K. Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease. Us Neurology. 7: 100-108. PMID 24348751 DOI: 10.17925/Usn.2011.07.02.100  0.138
2017 Lin M, Gong P, Yang T, Ye J, Albin RL, Dodge HH. Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Disease and Associated Disorders. PMID 29227306 DOI: 10.1097/Wad.0000000000000228  0.138
2012 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1609-17. PMID 22569194 DOI: 10.1038/Jcbfm.2012.60  0.138
2015 Bohnen NI, Albin RL, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. Jama Neurology. 72: 194-200. PMID 25506674 DOI: 10.1001/Jamaneurol.2014.2757  0.138
2000 Sullivan AA, Chervin RD, Albin RL. Parkinsonism after correction of hyponatremia with radiological central pontine myelinolysis and changes in the basal ganglia. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 7: 256-9. PMID 10833626 DOI: 10.1054/jocn.1999.0192  0.138
2005 Philips ST, Albin RL, Martin DM. Genetics of subthalamic nucleus in development and disease. Experimental Neurology. 192: 320-30. PMID 15755549 DOI: 10.1016/J.Expneurol.2004.11.008  0.137
2013 Müller ML, Frey KA, Petrou M, Kotagal V, Koeppe RA, Albin RL, Bohnen NI. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 296-301. PMID 23239424 DOI: 10.1002/Mds.25213  0.137
2014 Sarter M, Albin RL, Kucinski A, Lustig C. Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Experimental Neurology. 257: 120-9. PMID 24805070 DOI: 10.1016/j.expneurol.2014.04.032  0.137
1995 Albin RL, Tagle DA. Genetics and molecular biology of Huntington's disease. Trends in Neurosciences. 18: 11-4. PMID 7535483 DOI: 10.1016/0166-2236(95)93943-R  0.136
2014 Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Human Brain Mapping. 35: 792-809. PMID 23281100 DOI: 10.1002/Hbm.22214  0.136
2011 Bohnen NI, Müller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain : a Journal of Neurology. 134: 2358-65. PMID 21653540 DOI: 10.1093/Brain/Awr139  0.136
2017 Ryan KA, Hammers D, DeLeon A, Bilen H, Frey K, Burke J, Albin R, Barbas N, Heidebrink J, Giordani B. Agreement among neuropsychological and behavioral data and PiB findings in diagnosing Frontotemporal Dementia. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 28601570 DOI: 10.1016/J.Jocn.2017.05.008  0.135
2011 Burke JF, Albin RL. Do neurologists make a difference in Parkinson disease care? Neurology. 77: e52-3. PMID 21876194 DOI: 10.1212/WNL.0b013e31822f48fb  0.135
2017 Pappas SS, Bonifacino J, Danek A, Dauer WT, De M, De Franceschi L, DiPaolo G, Fuller R, Haucke V, Hermann A, Kornmann B, Landwehrmeyer B, Levin J, Neiman AM, Rudnicki DD, ... ... Albin RL, et al. Eighth International Chorea-Acanthocytosis Symposium: Summary of Workshop Discussion and Action Points. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 7: 428. PMID 28224046 DOI: 10.7916/D8XD127W  0.135
2015 Kucinski A, Albin RL, Lustig C, Sarter M. Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss. Behavioural Brain Research. 282: 155-64. PMID 25595423 DOI: 10.1016/j.bbr.2015.01.012  0.134
2015 Albin RL, Fisher-Hubbard A, Shanmugasundaram K, Koeppe RA, Burke JF, Camelo-Piragua S, Lieberman AP, Giordani B, Frey KA. Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications. Annals of Neurology. PMID 26183692 DOI: 10.1002/Ana.24481  0.134
2010 Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrometry Reviews. 29: 79-125. PMID 19358229 DOI: 10.1002/Mas.20221  0.134
2013 Albin RL, Burke JF, Koeppe RA, Giordani B, Gilman S, Frey KA. Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 887-93. PMID 23572495 DOI: 10.2967/Jnumed.112.112599  0.134
2012 Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Annals of Neurology. 71: 560-8. PMID 22522445 DOI: 10.1002/Ana.22691  0.133
2001 Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Human Molecular Genetics. 10: 137-44. PMID 11152661 DOI: 10.1093/Hmg/10.2.137  0.131
2002 Lavedan C, Buchholtz S, Nussbaum RL, Albin RL, Polymeropoulos MH. A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neuroscience Letters. 322: 57-61. PMID 11958843 DOI: 10.1016/S0304-3940(01)02513-7  0.131
2021 Mitchell SD, Albin RL, Dauer WT, Goudreau JL, Sidiropoulos C. Heterozygous VPS13A and PARK2 Mutations in a Patient with Parkinsonism and Seizures. Case Reports in Neurology. 13: 341-346. PMID 34248567 DOI: 10.1159/000515805  0.131
2003 Tallaksen-Greene SJ, Ordway JM, Crouse AB, Jackson WS, Detloff PJ, Albin RL. Hprt(CAG)146 mice: age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. The Journal of Comparative Neurology. 465: 205-19. PMID 12949782 DOI: 10.1002/Cne.10855  0.131
2013 Zeng L, Tallaksen-Greene SJ, Wang B, Albin RL, Paulson HL. The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease. Journal of Huntington's Disease. 2: 201-15. PMID 24683430 DOI: 10.3233/JHD-130058  0.13
2001 Albin RL. Samuel Adams' tremor. Neurology. 57: 1350. PMID 11591876 DOI: 10.1212/Wnl.57.7.1350  0.13
2020 Stewart B, Dean JG, Koek A, Chua J, Wabl R, Martin K, Davoodian N, Becker C, Himedan M, Kim A, Albin R, Chou KL, Kotagal V. Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports. Pharmacology Research & Perspectives. 8: e00688. PMID 33280274 DOI: 10.1002/prp2.688  0.129
2018 Tang X, Ross CA, Johnson H, Paulsen JS, Younes L, Albin RL, Ratnanather JT, Miller MI. Regional subcortical shape analysis in premanifest Huntington's disease. Human Brain Mapping. PMID 30376191 DOI: 10.1002/Hbm.24456  0.129
2006 Albin RL. Parkinson's disease: background, diagnosis, and initial management. Clinics in Geriatric Medicine. 22: 735-51, v. PMID 17000333 DOI: 10.1016/j.cger.2006.06.003  0.129
2016 Kotagal V, Lineback C, Bohnen NI, Albin RL. Orthostatic hypotension predicts motor decline in early Parkinson disease. Parkinsonism & Related Disorders. PMID 27639815 DOI: 10.1016/j.parkreldis.2016.09.011  0.129
1988 Greenamyre JT, Maragos WF, Albin RL, Penney JB, Young AB. Glutamate transmission and toxicity in Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 421-30. PMID 2900537 DOI: 10.1016/0278-5846(88)90102-9  0.129
2017 Powell LE, Wild MR, Glang A, Ibarra S, Gau JM, Perez A, Albin RW, O'Neil-Pirozzi TM, Wade SL, Keating T, Saraceno C, Slocumb J. The development and evaluation of a web-based programme to support problem-solving skills following brain injury. Disability and Rehabilitation. Assistive Technology. 1-12. PMID 29063800 DOI: 10.1080/17483107.2017.1389999  0.128
2013 Stutzbach LD, Xie SX, Naj AC, Albin R, Gilman S, Lee VM, Trojanowski JQ, Devlin B, Schellenberg GD. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathologica Communications. 1: 31. PMID 24252572 DOI: 10.1186/2051-5960-1-31  0.128
2017 Albin RL, Minderovic C, Koeppe RA. Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome. Eneuro. 4. PMID 28791334 DOI: 10.1523/ENEURO.0178-17.2017  0.127
2015 Albin RL, Miller RA. Mini-review: Retarding aging in murine genetic models of neurodegeneration. Neurobiology of Disease. 85: 73-80. PMID 26477301 DOI: 10.1016/j.nbd.2015.10.014  0.127
2020 Moniruzzaman M, Kadota A, Akash MS, Pruitt PJ, Miura K, Albin R, Dodge HH. Effects of physical activities on dementia-related biomarkers: A systematic review of randomized controlled trials. Alzheimer's & Dementia (New York, N. Y.). 6: e12109. PMID 33521235 DOI: 10.1002/trc2.12109  0.127
2020 Zhang H, Deng K, Li H, Albin RL, Guan Y. Deep Learning Identifies Digital Biomarkers for Self-Reported Parkinson's Disease. Patterns (New York, N.Y.). 1. PMID 32699844 DOI: 10.1016/j.patter.2020.100042  0.127
2012 Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Albin RL. Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Archives of Neurology. 69: 1628-31. PMID 22964894 DOI: 10.1001/Archneurol.2012.764  0.127
2011 Burke JF, Albin RL. Do neurologists make a difference in Parkinson disease care? Neurology. 77: 814-5. PMID 21832212 DOI: 10.1212/WNL.0b013e31822b0118  0.126
2016 Ridder A, Müller ML, Kotagal V, Frey KA, Albin RL, Bohnen NI. Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related Disorders. 34: 15-19. PMID 27742131 DOI: 10.1016/J.Parkreldis.2016.10.006  0.126
2012 Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, ... ... Albin RL, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Human Molecular Genetics. 21: 3500-12. PMID 22556362 DOI: 10.1093/Hmg/Dds161  0.125
2009 Bohnen NI, Müller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 73: 1670-6. PMID 19917989 DOI: 10.1212/Wnl.0B013E3181C1Ded6  0.125
2000 Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 54: 1753-9. PMID 10802780 DOI: 10.1212/Wnl.54.9.1753  0.125
2002 Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Annals of Neurology. 51: 767-71. PMID 12112084 DOI: 10.1002/Ana.10186  0.125
1992 Albin RL, Reiner A, Anderson KD, Dure LS, Handelin B, Balfour R, Whetsell WO, Penney JB, Young AB. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Annals of Neurology. 31: 425-30. PMID 1375014 DOI: 10.1002/Ana.410310412  0.125
2013 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism & Related Disorders. 19: 522-6. PMID 23462483 DOI: 10.1016/J.Parkreldis.2013.01.016  0.124
2001 Suzuki M, Desmond TJ, Albin RL, Frey KA. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse (New York, N.Y.). 41: 329-36. PMID 11494403 DOI: 10.1002/Syn.1089  0.124
2016 Zhu F, Panwar B, Dodge HH, Li H, Hampstead BM, Albin RL, Paulson HL, Guan Y. COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease. Scientific Reports. 6: 34567. PMID 27703197 DOI: 10.1038/Srep34567  0.124
2014 Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. Acs Chemical Neuroscience. 5: 718-30. PMID 24896980 DOI: 10.1021/Cn500103U  0.123
2021 Albin RL, Müller MLTM, Bohnen NI, Spino C, Sarter M, Koeppe RA, Szpara A, Kim K, Lustig C, Dauer WT. α4β2 Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders. Annals of Neurology. PMID 33977560 DOI: 10.1002/ana.26102  0.123
2011 Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain : a Journal of Neurology. 134: 1647-57. PMID 21555336 DOI: 10.1093/Brain/Awr089  0.123
2014 Kotagal V, Albin RL, Müller ML, Koeppe RA, Studenski S, Frey KA, Bohnen NI. Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 69: 1569-75. PMID 24864306 DOI: 10.1093/Gerona/Glu070  0.123
2016 Ringman JM, Monsell S, Ng DW, Zhou Y, Nguyen A, Coppola G, Van Berlo V, Mendez MF, Tung S, Weintraub S, Mesulam MM, Bigio EH, Gitelman DR, Fisher-Hubbard AO, Albin RL, et al. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. Journal of Neuropathology and Experimental Neurology. PMID 26888304 DOI: 10.1093/Jnen/Nlv028  0.123
2016 Petrou M, Davatzikos C, Hsieh M, Foerster BR, Albin RL, Kotagal V, Müller ML, Koeppe RA, Herman WH, Frey KA, Bohnen NI. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. Academic Radiology. PMID 26874576 DOI: 10.1016/J.Acra.2015.07.014  0.122
2021 Gornick MC, Ryan KA, Dayalu P, Carlozzi NE, Albin RL, Zahuranec DB. Huntington's Disease Community Perspectives on Desired Characteristics of Disease Modifying Therapies. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 11: 3. PMID 33569244 DOI: 10.5334/tohm.584  0.122
2009 Tallaksen-Greene SJ, Janiszewska A, Benton K, Hou G, Dick R, Brewer GJ, Albin RL. Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease. Neuroscience Letters. 452: 60-2. PMID 19429000 DOI: 10.1016/J.Neulet.2009.01.040  0.122
2016 Haugen J, Müller ML, Kotagal V, Albin RL, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26911386 DOI: 10.1007/S00702-016-1524-7  0.122
2019 Yang J, Archer DB, Burciu RG, Müller MLTM, Roy A, Ofori E, Bohnen NI, Albin RL, Vaillancourt DE. Multimodal dopaminergic and free-water imaging in Parkinson's disease. Parkinsonism & Related Disorders. PMID 30639168 DOI: 10.1016/J.Parkreldis.2019.01.007  0.122
2015 Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Albin RL, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157  0.121
2012 Lelieveld IM, Müller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, Albin RL. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. Plos One. 7: e40166. PMID 22792235 DOI: 10.1371/Journal.Pone.0040166  0.121
2016 Kumar A, Zhang J, Tallaksen-Greene S, Crowley MR, Crossman DK, Morton AJ, van Groen T, Kadish I, Albin RL, Lesort M, Detloff PJ. Allelic Series of Huntington's Disease Knock-in Mice Reveals Expression Discorrelates. Human Molecular Genetics. PMID 26908599 DOI: 10.1093/Hmg/Ddw040  0.121
2012 Kotagal V, Albin R, Muller M, Koeppe R, Frey K, Bohnen N. Diabetes Is Associated with Bradykinesia and Postural Instability and Gait Difficulty in Parkinson Disease Independent of Nigrostriatal Dopaminergic Denervation: A Case-Control Study (P07.125) Neurology. 78: P07.125-P07.125. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.125  0.121
2003 Albin RL, Frey KA. Initial agonist treatment of Parkinson disease: a critique. Neurology. 60: 390-4. PMID 12580185 DOI: 10.1212/01.Wnl.0000052681.28286.52  0.12
2012 Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Albin RL, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 DOI: 10.4161/Auto.19496  0.12
2008 Albin RL, Koeppe RA, Bohnen NI, Wernette K, Kilbourn MA, Frey KA. Spared caudal brainstem SERT binding in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 441-4. PMID 18073772 DOI: 10.1038/Sj.Jcbfm.9600599  0.12
1994 Bazzett TJ, Becker JB, Falik RC, Albin RL. Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity. Neuroscience. 60: 837-41. PMID 7523988 DOI: 10.1016/0306-4522(94)90266-6  0.119
2011 Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 848-55. PMID 21571793 DOI: 10.2967/Jnumed.111.089946  0.119
2006 Frey KA, Albin RL. Neuroimaging of Tourette syndrome. Journal of Child Neurology. 21: 672-7. PMID 16970868 DOI: 10.1177/08830738060210080501  0.119
2008 Kitsou E, Pan S, Zhang J, Shi M, Zabeti A, Dickson DW, Albin R, Gearing M, Kashima DT, Wang Y, Beyer RP, Zhou Y, Pan C, Caudle WM, Zhang J. Identification of proteins in human substantia nigra. Proteomics. Clinical Applications. 2: 776-82. PMID 21136874 DOI: 10.1002/Prca.200800028  0.118
1989 Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends in Neurosciences. 12: 366-75. PMID 2479133 DOI: 10.1016/0166-2236(89)90074-X  0.118
2018 Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, et al. Finding useful biomarkers for Parkinson's disease. Science Translational Medicine. 10. PMID 30111645 DOI: 10.1126/Scitranslmed.Aam6003  0.118
2015 Müller ML, Bohnen NI, Kotagal V, Scott PJ, Koeppe RA, Frey KA, Albin RL. Clinical markers for identifying cholinergic deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 269-73. PMID 25393613 DOI: 10.1002/Mds.26061  0.118
1995 Albin RL. The pathophysiology of chorea/ballism and Parkinsonism. Parkinsonism & Related Disorders. 1: 3-11. PMID 18590996 DOI: 10.1016/1353-8020(95)00011-T  0.118
2009 Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 72: 1390-6. PMID 19380698 DOI: 10.1212/Wnl.0B013E3181A187Dd  0.117
2003 Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 61: 310-5. PMID 12913189 DOI: 10.1212/01.Wnl.0000076181.39162.Fc  0.117
2010 Heng MY, Duong DK, Albin RL, Tallaksen-Greene SJ, Hunter JM, Lesort MJ, Osmand A, Paulson HL, Detloff PJ. Early autophagic response in a novel knock-in model of Huntington disease. Human Molecular Genetics. 19: 3702-20. PMID 20616151 DOI: 10.1093/Hmg/Ddq285  0.117
2012 Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, Albin RL, Hu H, Rozek LS. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. Journal of Alzheimer's Disease : Jad. 29: 571-88. PMID 22451312 DOI: 10.3233/Jad-2012-111223  0.116
2012 Bohnen N, Albin R, Kotagal V, Frey K, Muller M. Decreased Vestibular Efficacy Contributes To Balance Impairment in Parkinson Disease (PD4.009) Neurology. 78: PD4.009-PD4.009. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Pd4.009  0.116
2021 Kanel P, Bedard MA, Aghourian M, Rosa-Neto P, Soucy JP, Albin RL, Bohnen NI. Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views. Current Neurology and Neuroscience Reports. 21: 52. PMID 34545424 DOI: 10.1007/s11910-021-01140-z  0.116
2014 Postuma RB, Albin RL. Placebo: from belief to movement. Neurology. 82: 1390-1. PMID 24658928 DOI: 10.1212/WNL.0000000000000348  0.116
2010 Tallaksen-Greene SJ, Janiszewska A, Benton K, Ruprecht L, Albin RL. Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease. Experimental Neurology. 225: 402-7. PMID 20659453 DOI: 10.1016/j.expneurol.2010.07.015  0.115
2014 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology. 82: 1514-20. PMID 24682965 DOI: 10.1212/Wnl.0000000000000356  0.114
2002 Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. Journal of Geriatric Psychiatry and Neurology. 15: 200-9. PMID 12489916 DOI: 10.1177/089198870201500405  0.114
2014 Bohnen NI, Kotagal V, Müller ML, Koeppe RA, Scott PJ, Albin RL, Frey KA, Petrou M. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related Disorders. 20: 1394-8. PMID 25454317 DOI: 10.1016/J.Parkreldis.2014.10.008  0.114
1979 Albin R, Wiener J, Gordon R, Willoughby JH. Diagnosis and treatment of pansinusitis: Report of case Journal of Oral Surgery. 37: 604-607. PMID 286782  0.114
1999 Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53: 371-4. PMID 10430428 DOI: 10.1212/Wnl.53.2.371  0.113
2006 Yu Z, Dadgar N, Albertelli M, Scheller A, Albin RL, Robins DM, Lieberman AP. Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. The American Journal of Pathology. 168: 195-204. PMID 16400023 DOI: 10.2353/Ajpath.2006.050619  0.113
2015 Zeng L, Wang B, Merillat SA, Minakawa E, Perkins MD, Ramani B, Tallaksen-Greene SJ, Costa MD, Albin RL, Paulson HL. Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3. Neurobiology of Disease. PMID 26141599 DOI: 10.1016/j.nbd.2015.06.017  0.113
1991 Albin RL, Qin Y, Young AB, Penney JB, Chesselet MF. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study. Annals of Neurology. 30: 542-9. PMID 1838677 DOI: 10.1002/ana.410300406  0.112
2019 Zhou Z, Müller MLTM, Kanel P, Chua J, Kotagal V, Kaufer DI, Albin RL, Frey KA, Bohnen NI. Apathy rating scores and β-amyloidopathy in Parkinson disease patients at risk for cognitive decline. Neurology. PMID 31732566 DOI: 10.1212/Wnl.0000000000008683  0.112
2013 Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Müller ML. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 81: 1611-6. PMID 24078735 DOI: 10.1212/Wnl.0B013E3182A9F558  0.112
2008 Shi M, Jin J, Wang Y, Beyer RP, Kitsou E, Albin RL, Gearing M, Pan C, Zhang J. Mortalin: a protein associated with progression of Parkinson disease? Journal of Neuropathology and Experimental Neurology. 67: 117-24. PMID 18219256 DOI: 10.1097/Nen.0B013E318163354A  0.112
2003 Albin RL. Dominant ataxias and Friedreich ataxia: an update. Current Opinion in Neurology. 16: 507-14. PMID 12869811 DOI: 10.1097/01.wco.0000084230.82329.d5  0.112
2005 Tallaksen-Greene SJ, Crouse AB, Hunter JM, Detloff PJ, Albin RL. Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knockin mice. Neuroscience. 131: 843-52. PMID 15749339 DOI: 10.1016/J.Neuroscience.2004.10.037  0.112
1995 Baker DJ, Fox J, Albin RW. Staff support strategies to increase the involvement of individuals with disabilities in meal preparation Behavioral Interventions. 10: 197-210. DOI: 10.1002/bin.2360100403  0.112
1998 Albin RL. Cerebellar input tremor. Neurology. 50: 307-8. PMID 9443505 DOI: 10.1212/Wnl.50.1.307-A  0.111
2011 Prust M, Wang J, Morizono H, Messing A, Brenner M, Gordon E, Hartka T, Sokohl A, Schiffmann R, Gordish-Dressman H, Albin R, Amartino H, Brockman K, Dinopoulos A, Dotti MT, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 77: 1287-94. PMID 21917775 DOI: 10.1212/Wnl.0B013E3182309F72  0.111
2016 Albin RL, Frey KA. Reverse Translation in Parkinson Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27151982 DOI: 10.2967/Jnumed.116.175257  0.111
2003 Albin RL. Neuroprotective agents for clinical trials in Parkinson's disease: A public policy experiment Neurology. 60: 1225.  0.111
2012 Albin RG, Perez-Cárdenas JC. Clinic-histopathologic diagnosis of the kaposi's sarcoma Sarcoma: Symptoms, Causes and Treatments. 35-62.  0.111
2012 Andreev VP, Petyuk VA, Brewer HM, Karpievitch YV, Xie F, Clarke J, Camp D, Smith RD, Lieberman AP, Albin RL, Nawaz Z, El Hokayem J, Myers AJ. Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains. Journal of Proteome Research. 11: 3053-67. PMID 22559202 DOI: 10.1021/Pr3001546  0.111
1993 Kremer B, Tallaksen-Greene SJ, Albin RL. AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease. Neurology. 43: 1593-5. PMID 7688883 DOI: 10.1212/WNL.43.8.1593  0.111
2015 Albin RL, Burke JF. Potential trade-offs in treatment of premanifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1319-23. PMID 26173644 DOI: 10.1002/mds.26318  0.11
2009 Fink DJ, Albin RL. What sort of change to believe in: an alternate opinion. Annals of Neurology. 65: 619. PMID 19475662 DOI: 10.1002/ana.21669  0.11
2020 Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P, Thompson T. Current and projected future economic burden of Parkinson's disease in the U.S. Npj Parkinson's Disease. 6: 15. PMID 32665974 DOI: 10.1038/S41531-020-0117-1  0.11
2012 Kotagal V, Albin RL, Müller ML, Bohnen NI. Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology. 79: 1835-6; author reply. PMID 23251922  0.109
2015 Shah N, Frey KA, L T M Müller M, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26380951 DOI: 10.1002/Mds.26369  0.109
2010 Heng MY, Detloff PJ, Paulson HL, Albin RL. Early alterations of autophagy in Huntington disease-like mice. Autophagy. 6: 1206-8. PMID 20935460 DOI: 10.4161/Auto.6.8.13617  0.109
1992 Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology. 42: 733-8. PMID 1314341 DOI: 10.1212/Wnl.42.4.733  0.109
2013 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1421-4. PMID 23532360 DOI: 10.1007/S00702-013-1013-1  0.108
1998 Kieburtz K, Frey K, Albin R, Marek K, Bates G, Aylward E, Guttman M, Rouleau G, Baehr M, Pahwa R, Lyons KE, Wilkinson SB, Kieltyka J, Koller WC, Bertoni JM, et al. Twelfth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Etiology, Pathogenesis, and Treatment of Huntington's Disease, Queen Elizabeth Hotel, Montreal, Canada, 18 October 1998 Movement Disorders. 13: 858-863. DOI: 10.1002/Mds.870130522  0.108
2017 Albin RL, Leventhal DK. The Missing, The Short, and The Long: L-Dopa Responses and Dopamine Actions. Annals of Neurology. PMID 28543679 DOI: 10.1002/Ana.24961  0.108
2017 Bohnen NI, Haugen J, Ridder A, Kotagal V, Albin RL, Frey KA, Müller MLTM. Color discrimination errors associate with axial motor impairments in Parkinson's disease. Movement Disorders Clinical Practice. 4: 864-869. PMID 29226177 DOI: 10.1002/Mdc3.12527  0.108
2002 Suzuki M, Desmond TJ, Albin RL, Frey KA. Cholinergic vesicular transporters in progressive supranuclear palsy. Neurology. 58: 1013-8. PMID 11940684 DOI: 10.1212/Wnl.58.7.1013  0.108
2017 Albin RL. What would Dr. James Parkinson think today? II. Neuroimaging in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 179-180. PMID 28218459 DOI: 10.1002/mds.26951  0.108
2013 Kucinski A, Paolone G, Bradshaw M, Albin RL, Sarter M. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 16522-39. PMID 24133257 DOI: 10.1523/JNEUROSCI.2545-13.2013  0.108
2013 Antonini A, Albin RL. Dopaminergic treatment and nonmotor features of Parkinson disease: the horse lives. Neurology. 80: 784-5. PMID 23365050 DOI: 10.1212/WNL.0b013e318285c16d  0.107
2014 Dodge HH, Zhu J, Harvey D, Saito N, Silbert LC, Kaye JA, Koeppe RA, Albin RL. Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 690-703. PMID 25022534 DOI: 10.1016/J.Jalz.2014.04.513  0.107
2021 Bohnen NI, Kanel P, Koeppe RA, Sanchez-Catasus CA, Frey KA, Scott P, Constantine GM, Albin RL, Müller MLTM. Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease Brain Communications. 3. DOI: 10.1093/BRAINCOMMS/FCAB109  0.106
1993 Bazzett TJ, Becker JB, Kaatz KW, Albin RL. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration. Experimental Neurology. 120: 177-85. PMID 8387931 DOI: 10.1006/exnr.1993.1053  0.105
2017 Kotagal V, Bohnen NI, Müller ML, Frey KA, Albin RL. Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease. Journal of Parkinson's Disease. PMID 28106566 DOI: 10.3233/Jpd-160985  0.105
2012 Ghetti B, Murrell J, Koeppe R, Gilman S, Fink J, Miravalle L, Albin R, Vidal R, Foster N. Follow-up of the first American report of familial Alzheimer's disease Alzheimers & Dementia. 8: 665. DOI: 10.1016/J.Jalz.2012.05.1793  0.104
2012 Bly B, Muller M, Albin R, Frey K, Bohnen N. The Prevalence of Impaired Olfaction in Parkinson's Disease Is Higher Than Previously Estimated (P07.129) Neurology. 78: P07.129-P07.129. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.129  0.104
2009 Heng MY, Detloff PJ, Wang PL, Tsien JZ, Albin RL. In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 3200-5. PMID 19279257 DOI: 10.1523/Jneurosci.5599-08.2009  0.104
1990 Albin RL, Albers JW. Long-term follow-up of pyridoxine-induced acute sensory neuropathy-neuronopathy. Neurology. 40: 1319. PMID 2166252 DOI: 10.1212/WNL.40.8.1319  0.104
1995 Shukla S, Surratt AV, Horner RH, Albin RW. Case study: Examining the relationship between self-initiations of an individual with disabilities and directive behavior of staff persons in a residential setting Behavioral Interventions. 10: 101-110. DOI: 10.1002/Bin.2360100206  0.104
2014 Burke JF, Langa KM, Hayward RA, Albin RL. Modeling test and treatment strategies for presymptomatic Alzheimer disease. Plos One. 9: e114339. PMID 25474698 DOI: 10.1371/journal.pone.0114339  0.103
1998 Shear DA, Dong J, Haik-Creguer KL, Bazzett TJ, Albin RL, Dunbar GL. Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task. Experimental Neurology. 150: 305-11. PMID 9527900 DOI: 10.1006/Exnr.1998.6767  0.103
2007 Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA, Sathasivam K, Cha JH, Hannan AJ, Hayden MR, Leavitt BR, Dunnett SB, Ferrante RJ, ... Albin R, et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Human Molecular Genetics. 16: 1845-61. PMID 17519223 DOI: 10.1093/Hmg/Ddm133  0.103
1993 Jones JM, Albin RL, Feldman EL, Simin K, Schuster TG, Dunnick WA, Collins JT, Chrisp CE, Taylor BA, Meisler MH. mnd2: a new mouse model of inherited motor neuron disease. Genomics. 16: 669-77. PMID 8325640 DOI: 10.1006/Geno.1993.1246  0.102
1988 Albin RR. The Perkins Case: The Ordeal of Three Slaves in Gold Rush California California History. 67: 215-227. DOI: 10.2307/25158492  0.102
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Albin RL, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  0.102
2011 Hammers D, Spurgeon E, Ryan K, Persad C, Heidebrink J, Barbas N, Albin R, Frey K, Darby D, Giordani B. Reliability of repeated cognitive assessment of dementia using a brief computerized battery American Journal of Alzheimer's Disease and Other Dementias. 26: 326-333. PMID 21636581 DOI: 10.1177/1533317511411907  0.102
2004 Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. Journal of Chemical Neuroanatomy. 27: 143-64. PMID 15183201 DOI: 10.1016/j.jchemneu.2004.02.005  0.102
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Albin RL, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7  0.102
2018 Bohnen NI, Albin RL. Hypercholinergic activity in LRRK2 Parkinson's disease. The Lancet. Neurology. PMID 29456160 DOI: 10.1016/S1474-4422(18)30073-5  0.102
2014 Tallaksen-Greene SJ, Sadagurski M, Zeng L, Mauch R, Perkins M, Banduseela VC, Lieberman AP, Miller RA, Paulson HL, Albin RL. Differential effects of delayed aging on phenotype and striatal pathology in a murine model of Huntington disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 15658-68. PMID 25411494 DOI: 10.1523/JNEUROSCI.1830-14.2014  0.101
2008 Heng MY, Detloff PJ, Albin RL. Rodent genetic models of Huntington disease. Neurobiology of Disease. 32: 1-9. PMID 18638556 DOI: 10.1016/J.Nbd.2008.06.005  0.101
2015 Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Langa KM, Albin RL. Educational attainment and motor burden in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1143-7. PMID 26096339 DOI: 10.1002/Mds.26272  0.101
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Albin R, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.101
1999 Bohnen NI, Albin RL, Frey KA, Fink JK. (+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis. Neurology. 52: 1067-9. PMID 10102431 DOI: 10.1212/Wnl.52.5.1067  0.1
1988 Albin RL, Silverman AK, Ellis CN, Voorhees JJ, Albers JW. A new syndrome of axial muscle rigidity associated with etretinate therapy. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 70-6. PMID 3173366 DOI: 10.1002/mds.870030109  0.1
1982 Lisch M, Mittleman M, Albin R. Digital lipoma of the foot: An extraordinary case Journal of Foot Surgery. 21: 330-334. PMID 7186924  0.1
2018 Kotagal V, Albin RL, Müller MLTM, Bohnen NI. Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease. Journal of Parkinson's Disease. 8: 153-160. PMID 29480230 DOI: 10.3233/JPD-171271  0.099
2011 Chotinaiwattarakul W, Dayalu P, Chervin RD, Albin RL. Risk of sleep-disordered breathing in Parkinson's disease. Sleep & Breathing = Schlaf & Atmung. 15: 471-8. PMID 20473719 DOI: 10.1007/s11325-010-0362-3  0.099
2000 Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine. 6: 991-7. PMID 10973318 DOI: 10.1038/79690  0.099
2003 Albin RL, Cross D, Cornblath WT, Wald JA, Wernette K, Frey KA, Minoshima S. Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Annals of Neurology. 53: 528-32. PMID 12666122 DOI: 10.1002/Ana.10527  0.099
1990 Albin RJ. Sarcoidosis in the elderly: Expect the unexpected - A case report Respiratory Care. 35: 811-814.  0.099
2013 Müller MLTM, Albin RL, Bohnen NI. Association of cardinal motor symptoms with region-specific dopamine transporter activity in mild to moderate parkinson's disease European Neurological Journal. 4.  0.099
2011 Ness BM, Sohlberg MM, Albin RW. Evaluation of a second-tier classroom-based assignment completion strategy for middle school students in a resource context Remedial and Special Education. 32: 406-416. DOI: 10.1177/0741932510362493  0.099
2021 Moinuddin O, Khandwala NS, Young KZ, Sathrasala SK, Barmada SJ, Albin RL, Besirli CG. Role of Optical Coherence Tomography in Identifying Retinal Biomarkers in Frontotemporal Dementia: A Review. Neurology. Clinical Practice. 11: e516-e523. PMID 34484950 DOI: 10.1212/CPJ.0000000000001041  0.098
1990 Albin RL. The death of Nicholas Bolkonski. Neurology in Tolstoy's War and Peace. Archives of Neurology. 47: 225-6. PMID 2302093 DOI: 10.1001/archneur.1990.00530020137029  0.097
2014 Bohnen NI, Müller ML, Dauer WT, Albin RL. Parkinsons disease: What role do pedunculopontine cholinergic neurons play? Future Neurology. 9: 5-8. DOI: 10.2217/fnl.13.61  0.097
1990 Albin RL, Reiner A, Anderson KD, Penney JB, Young AB. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Annals of Neurology. 27: 357-65. PMID 1972318 DOI: 10.1002/Ana.410270403  0.097
1988 Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D'Amato C, Shoulson I, Penney JB. NMDA receptor losses in putamen from patients with Huntington's disease. Science (New York, N.Y.). 241: 981-3. PMID 2841762 DOI: 10.1126/Science.2841762  0.097
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Albin RL, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2  0.097
2000 Albin RL. Basal ganglia neurotoxins. Neurologic Clinics. 18: 665-80. PMID 10873237 DOI: 10.1016/S0733-8619(05)70217-6  0.096
2004 Lorincz MT, Detloff PJ, Albin RL, O'Shea KS. Embryonic stem cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expression. Molecular and Cellular Neurosciences. 26: 135-43. PMID 15121185 DOI: 10.1016/j.mcn.2004.01.016  0.096
1998 Lavedan C, Buchholtz S, Auburger G, Albin RL, Athanassiadou A, Blancato J, Burguera JA, Ferrell RE, Kostic V, Leroy E, Leube B, Mota-Vieira L, Papapetropoulos T, Pericak-Vance MA, Pinkus J, et al. Absence of mutation in the beta- and gamma-synuclein genes in familial autosomal dominant Parkinson's disease. Dna Research : An International Journal For Rapid Publication of Reports On Genes and Genomes. 5: 401-2. PMID 10048491 DOI: 10.1093/Dnares/5.6.401  0.095
2019 Archer DB, Bricker JT, Chu WT, Burciu RG, Mccracken JL, Lai S, Coombes SA, Fang R, Barmpoutis A, Corcos DM, Kurani AS, Mitchell T, Black ML, Herschel E, Simuni T, ... ... Albin RL, et al. Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. The Lancet. Digital Health. 1: e222-e231. PMID 32259098 DOI: 10.1016/s2589-7500(19)30105-0  0.095
1988 Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America. 85: 5733-7. PMID 2456581 DOI: 10.1073/Pnas.85.15.5733  0.095
2017 Albin RL. Response to Gooch et al. Annals of Neurology. PMID 28752897 DOI: 10.1002/ana.25001  0.095
2003 Jackson WS, Tallaksen-Greene SJ, Albin RL, Detloff PJ. Nucleocytoplasmic transport signals affect the age at onset of abnormalities in knock-in mice expressing polyglutamine within an ectopic protein context. Human Molecular Genetics. 12: 1621-9. PMID 12812988 DOI: 10.1093/Hmg/Ddg163  0.095
2015 Snider J, Müller ML, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Albin RL, Bohnen NI. Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration. Parkinsonism & Related Disorders. PMID 26330028 DOI: 10.1016/J.Parkreldis.2015.08.027  0.094
1993 Albin RL. Antagonistic pleiotropy, mutation accumulation, and human genetic disease. Genetica. 91: 279-86. PMID 8125276 DOI: 10.1007/BF01436004  0.094
2004 Rainier S, Thomas D, Tokarz D, Ming L, Bui M, Plein E, Zhao X, Lemons R, Albin R, Delaney C, Alvarado D, Fink JK. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Jama Neurology. 61: 1025-1029. PMID 15262732 DOI: 10.1001/Archneur.61.7.1025  0.093
1995 Albin RL. Selective neurodegeneration in Huntington's disease. Annals of Neurology. 38: 835-6. PMID 8526454 DOI: 10.1002/ana.410380602  0.093
2005 Albin RL. Report from the neurology scientific integrity advisor: year 1. Neurology. 65: 781; author reply 78. PMID 16157929  0.092
2008 Haut SR, Albin RL. Dopamine and epilepsy: hints of complex subcortical roles. Neurology. 71: 784-5. PMID 18779507 DOI: 10.1212/01.wnl.0000325637.38931.27  0.092
2007 Pan S, Shi M, Jin J, Albin RL, Lieberman A, Gearing M, Lin B, Pan C, Yan X, Kashima DT, Zhang J. Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Molecular & Cellular Proteomics : McP. 6: 1818-23. PMID 17644759 DOI: 10.1074/Mcp.M700158-Mcp200  0.092
2003 Feeley Kearney JA, Albin RL. mGluRs: a target for pharmacotherapy in Parkinson disease. Experimental Neurology. 184: S30-6. PMID 14597323 DOI: 10.1016/S0014-4886(03)00391-1  0.092
2019 Martin WRW, Albin RL. Huntington disease: When does it begin? Neurology. PMID 31371566 DOI: 10.1212/WNL.0000000000008054  0.092
1988 Albin RL, Bromberg MB, Penney JB, Knapp R. Chorea and dystonia: a remote effect of carcinoma. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 162-9. PMID 2851739 DOI: 10.1002/Mds.870030208  0.092
1997 Ordway JM, Tallaksen-Greene S, Gutekunst CA, Bernstein EM, Cearley JA, Wiener HW, Dure LS, Lindsey R, Hersch SM, Jope RS, Albin RL, Detloff PJ. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 91: 753-63. PMID 9413985 DOI: 10.1016/S0092-8674(00)80464-X  0.092
1993 Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genetics. 5: 259-65. PMID 8275091 DOI: 10.1038/Ng1193-259  0.091
2015 Uhlmann WR, Peñaherrera MS, Robinson WP, Milunsky JM, Nicholson JM, Albin RL. Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology. American Journal of Medical Genetics. Part A. 167: 1152-60. PMID 25736541 DOI: 10.1002/ajmg.a.37009  0.091
1993 Curran EJ, Albin RL, Becker JB. Adrenal medulla grafts in the hemiparkinsonian rat: profile of behavioral recovery predicts restoration of the symmetry between the two striata in measures of pre- and postsynaptic dopamine function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 3864-77. PMID 8103552 DOI: 10.1523/Jneurosci.13-09-03864.1993  0.091
2012 Kotagal V, Albin R, Muller M, Koeppe R, Frey K, Bohnen N. Bradykinesia, Rigidity, and Postural Instability and Gait Difficulty Occur More Commonly in Men with Parkinson Disease Compared to Women Independent of Nigrostriatal Dopaminergic Denervation (P06.044) Neurology. 78: P06.044-P06.044. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.044  0.091
2012 Shao X, Carpenter GM, Desmond TJ, Sherman P, Quesada CA, Fawaz M, Brooks AF, Kilbourn MR, Albin RL, Frey KA, Scott PJ. Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles. Acs Medicinal Chemistry Letters. 3: 936-41. PMID 24900410 DOI: 10.1021/Ml300216T  0.09
2018 Kotagal V, Spino C, Bohnen NI, Koeppe RA, Albin RL. Serotonin, beta-amyloid, and cognition in Parkinson disease. Annals of Neurology. PMID 29665066 DOI: 10.1002/Ana.25236  0.089
1996 Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AA. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 47: 462-6. PMID 8757021 DOI: 10.1212/Wnl.47.2.462  0.089
1999 Pennell PB, Burdette DE, Ross DA, Henry TR, Albin RL, Sackellares JC, Frey KA. Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia. 40: 38-46. PMID 9924900 DOI: 10.1111/J.1528-1157.1999.Tb01986.X  0.088
1995 Kaatz KW, Albin RL. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioral and Fos immunohistochemical study. Neuroscience. 66: 55-65. PMID 7637875 DOI: 10.1016/0306-4522(94)00568-P  0.088
2017 Garcia S, Kavcic V, Shair S, Dodge H, Bhaumik AK, Rose E, Campbell S, Teboe S, Overall J, Hampstead BM, Lichtenberg P, Heidebrink JL, Barbas NR, Albin RL, Paulson HL, et al. Race And Amnestic Mci Subtype Performance In Comparison To Healthy Older Controls On The Nih Toolbox-Cognitive Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.485  0.088
1994 Turgeon SM, Albin RL. Postnatal ontogeny of GABAB binding in rat brain. Neuroscience. 62: 601-13. PMID 7830900 DOI: 10.1016/0306-4522(94)90392-1  0.088
2001 Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology. 50: 358-65. PMID 11558792 DOI: 10.1002/Ana.1133  0.087
1981 Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. The Journal of Bone and Joint Surgery. American Volume. 63: 787-97. PMID 7240301  0.087
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Albin RL, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491  0.087
2002 Albin RL. Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls. Journal of Medical Ethics. 28: 322-5. PMID 12356962 DOI: 10.1136/jme.28.5.322  0.087
2019 Kotagal V, Szpara A, Albin RL, Bohnen NI. Fatigue in Parkinson's Disease Associates with Lower Ambulatory Diastolic Blood Pressure. Journal of Parkinson's Disease. PMID 31156183 DOI: 10.3233/JPD-191579  0.087
2011 Garg SK, Vitvitsky V, Albin R, Banerjee R. Astrocytic redox remodeling by amyloid beta peptide Antioxidants and Redox Signaling. 14: 2385-2397. PMID 21235355 DOI: 10.1089/Ars.2010.3681  0.086
2003 Kemmerer ES, Desmond TJ, Albin RL, Kilbourn MR, Frey KA. Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Experimental Neurology. 183: 81-6. PMID 12957491 DOI: 10.1016/S0014-4886(03)00096-7  0.085
1997 Lucyshyn JM, Albin RW, Nixon CD. Embedding comprehensive behavioral support in family ecology: An experimental, single-case analysis Journal of Consulting and Clinical Psychology. 65: 241-251. PMID 9086687 DOI: 10.1037/0022-006X.65.2.241  0.085
2006 Albin R, Koeppe R. Rapid loss of striatal VMAT2 binding associated with onset of lewy body dementia [5] Movement Disorders. 21: 287-288. PMID 16258980 DOI: 10.1002/Mds.20733  0.084
2010 Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of Neurology. 67: 440-6. PMID 20385910 DOI: 10.1001/Archneurol.2010.34  0.083
1994 Albin RL, Howland MM, Higgins DS, Frey KA. Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain. Neurochemical Research. 19: 581-9. PMID 8065514 DOI: 10.1007/Bf00971334  0.083
1996 Bazzett TJ, Falik RC, Becker JB, Albin RL. Chronic intrastriatal administration of quinolinic acid produces transient nocturnal hypermotility in the rat. Brain Research Bulletin. 39: 69-73. PMID 8846115 DOI: 10.1016/0361-9230(95)02043-8  0.083
1992 Tallaksen-Greene SJ, Wiley RG, Albin RL. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Research. 594: 165-70. PMID 1334764 DOI: 10.1016/0006-8993(92)91044-F  0.083
2013 Chung S, Bohnen NI, Albin RL, Frey KA, Müller ML, Chervin RD. Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 9: 1131-7. PMID 24235893 DOI: 10.5664/Jcsm.3150  0.082
2000 Zhang C, Albin RL. Increased response to intrastriatal L(+)-2-amino-4-phosphonobutyrate (L-AP4) in unilateral 6-hydroxydopamine-lesioned rats. Experimental Neurology. 165: 278-84. PMID 10993688 DOI: 10.1006/exnr.2000.7452  0.082
1998 Kearney JA, Becker JB, Frey KA, Albin RL. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation. Neuroscience. 87: 881-91. PMID 9759976 DOI: 10.1016/S0306-4522(98)00193-6  0.082
1994 Aldrich MS, Prokopowicz G, Ockert K, Hollingsworth Z, Penney JB, Albin RL. Neurochemical studies of human narcolepsy: alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem. Sleep. 17: 598-608. PMID 7846457 DOI: 10.1093/Sleep/17.7.598  0.082
1996 Tallaksen-Greene SJ, Albin RL. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons. Neuroscience. 75: 1057-64. PMID 8938741 DOI: 10.1016/0306-4522(96)00337-5  0.082
2003 Gehring WJ, Bryck RL, Jonides J, Albin RL, Badre D. The mind's eye, looking inward? In search of executive control in internal attention shifting. Psychophysiology. 40: 572-85. PMID 14570165 DOI: 10.1111/1469-8986.00059  0.082
1991 Albin RL, Makowiec RL, Hollingsworth Z, Sakurai SY, Dure LS, Penney JB, Young AB. Excitatory amino acidergic pathways and receptors in the basal ganglia. Amino Acids. 1: 339-50. PMID 24194174 DOI: 10.1007/BF00814003  0.081
1996 Kaatz KW, Albin RL. Intraseptal administration of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid induces immediate early gene expression in lateral septal neurons. Brain Research. 709: 205-14. PMID 8833756 DOI: 10.1016/0006-8993(95)01276-1  0.081
1995 Bazzett TJ, Falik RC, Becker JB, Albin RL. Chronic administration of malonic acid produces selective neural degeneration and transient changes in calbindin immunoreactivity in rat striatum. Experimental Neurology. 134: 244-52. PMID 7556544 DOI: 10.1006/exnr.1995.1054  0.081
1995 Albin RW, O'Brien M, Horner RH. Analysis of an escalating sequence of problem behaviors: A case study Research in Developmental Disabilities. 16: 133-147. PMID 7792409 DOI: 10.1016/0891-4222(95)00005-4  0.081
2005 Albin RL. Sham surgery controls are mitigated trolleys. Journal of Medical Ethics. 31: 149-52. PMID 15738434 DOI: 10.1136/jme.2003.006155  0.081
1997 Kearney JA, Frey KA, Albin RL. Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4415-25. PMID 9151758  0.081
1997 Kearney JAF, Frey KA, Albin RL. Metabotropic Glutamate Agonist-Induced Rotation: A Pharmacological, FOS Immunohistochemical, and [14C]-2-Deoxyglucose Autoradiographic Study The Journal of Neuroscience. 17: 4415-4425. DOI: 10.1523/Jneurosci.17-11-04415.1997  0.081
2006 Zhukareva V, Joyce S, Schuck T, Van Deerlin V, Hurtig H, Albin R, Gilman S, Chin S, Miller B, Trojanowski JQ, Lee VM. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter. Annals of Neurology. 60: 335-45. PMID 16823854 DOI: 10.1002/Ana.20916  0.08
2010 Albin RC. Patents, Innovation, and Privatization: Commentary on: "Data Management in Academic Settings: An Intellectual Property Perspective" Science and Engineering Ethics. 16: 777-781. PMID 20882419 DOI: 10.1007/s11948-010-9234-2  0.08
2000 Shankar VN, Albin RB, Milton JC, Nebergall M. In-service, performance-based roadside design policy: Preliminary insights from Washington State's bridge rail study Transportation Research Record. 72-79.  0.08
2015 Kotagal V, Langa KM, Plassman BL, Fisher GG, Giordani BJ, Wallace RB, Burke JR, Steffens DC, Kabeto M, Albin RL, Foster NL. Factors associated with cognitive evaluations in the United States. Neurology. 84: 64-71. PMID 25428689 DOI: 10.1212/Wnl.0000000000001096  0.08
2013 Hockley BG, Stewart MN, Sherman P, Quesada C, Kilbourn MR, Albin RL, Scott PJ. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use. Journal of Labelled Compounds & Radiopharmaceuticals. 56: 595-9. PMID 24285235 DOI: 10.1002/Jlcr.3069  0.08
2013 Meisler MH, Grant AE, Jones JM, Lenk GM, He F, Todd PK, Kamali M, Albin RL, Lieberman AP, Langenecker SA, McInnis MG. C9ORF72 expansion in a family with bipolar disorder. Bipolar Disorders. 15: 326-32. PMID 23551834 DOI: 10.1111/Bdi.12063  0.08
2018 Albin RL, Bohnen NI, Muller ML, Dauer WT, Sarter M, Frey KA, Koeppe RA. Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [ F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study. The Journal of Comparative Neurology. PMID 30255936 DOI: 10.1002/Cne.24541  0.08
2016 Albin RL, Edlow BL, Rosenthal ES, Hinson HE. Blowing the whistle on sports concussions: Will the risk of dementia change the game? Neurology. 86: 1929-30. PMID 27185899 DOI: 10.1212/01.wnl.0000484015.90990.ab  0.079
2020 Albin RL, Kordower JH. A Failed Future. Movement Disorders : Official Journal of the Movement Disorder Society. 35: 1299-1301. PMID 32780511 DOI: 10.1002/Mds.28130  0.079
1999 Bazzett T, Legnard E, Bauter MR, Albin RL. Time-course analysis and comparison of acute and chronic intrastriatal quinolinic acid administration on forelimb reaching deficits in the rat. Experimental Neurology. 158: 126-34. PMID 10448424 DOI: 10.1006/exnr.1999.7070  0.079
1987 Albin RL, Albers JW, Greenberg HS, Townsend JB, Lynn RB, Burke JM, Alessi AG. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology. 37: 1729-32. PMID 2823181 DOI: 10.1212/Wnl.37.11.1729  0.078
1999 Dickson DW, Liu W, Hardy J, Farrer M, Mehta N, Uitti R, Mark M, Zimmerman T, Golbe L, Sage J, Sima A, D'Amato C, Albin R, Gilman S, Yen SH. Widespread alterations of alpha-synuclein in multiple system atrophy. The American Journal of Pathology. 155: 1241-51. PMID 10514406 DOI: 10.1016/S0002-9440(10)65226-1  0.078
1995 Aisner SC, Albin RJ, Templeton PA, Krasna MJ. Endobronchial fibrous histiocytoma The Annals of Thoracic Surgery. 60: 710-712. PMID 7677514 DOI: 10.1016/0003-4975(95)00212-4  0.078
2012 Vitvitsky VM, Garg SK, Keep RF, Albin RL, Banerjee R. Na+ and K+ ion imbalances in Alzheimer's disease. Biochimica Et Biophysica Acta. 1822: 1671-81. PMID 22820549 DOI: 10.1016/J.Bbadis.2012.07.004  0.078
1994 Tallaksen-Greene SJ, Albin RL. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience. 61: 509-19. PMID 7969927 DOI: 10.1016/0306-4522(94)90430-8  0.078
1990 Chu DC, Albin RL, Young AB, Penney JB. Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study. Neuroscience. 34: 341-57. PMID 2159128 DOI: 10.1016/0306-4522(90)90144-S  0.078
2014 Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 396-404. PMID 24481024 DOI: 10.2967/Jnumed.113.124792  0.078
2019 Albin RL. Tourette Syndrome as a Disorder of the Social Decision Making Network. Frontiers in Psychiatry. 10: 742. PMID 31649568 DOI: 10.3389/fpsyt.2019.00742  0.078
2008 Albin RL, Koeppe RA, Rainier S, Fink JK. Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia. Journal of Neurogenetics. 22: 289-94. PMID 19085270 DOI: 10.1080/01677060802337307  0.078
2008 Ford AI, Simmons K, Wang C, Staffend N, Bhaumik A, Darby D, Nan B, Persad C, Heidebrink J, Nyquist L, Albin R, Giordani B. P3-127: Identification of cognitive decline using a longitudinal telephone screening versus brief, one-day computerized testing Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1692  0.078
1989 Horner RH, Albin RW, Mank DM. Effects of undesirable, competing behaviors on the generalization of adaptive skills: A case study Behavior Modification. 13: 74-90. PMID 2923615 DOI: 10.1177/01454455890131005  0.077
1998 Tallaksen-Greene SJ, Kaatz KW, Romano C, Albin RL. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Research. 780: 210-7. PMID 9507137 DOI: 10.1016/S0006-8993(97)01141-4  0.077
1993 Albin RL. Animal Models of Neurological Disease, I: Neurodegenerative Diseases. Alan A. Boulton , Glen B. Baker , Roger F. ButterworthAnimal Models of Neurological Disease, II: Metabolic Encephalopathies and the Epilepsies. Alan A. Boulton , Glen B. Baker , Roger F. Butterworth The Quarterly Review of Biology. 68: 305-305. DOI: 10.1086/418141  0.077
1993 Sakurai SY, Lutz PL, Schulman A, Albin RL. Unchanged [3H]MK-801 binding and increased [3H]flunitrazepam binding in turtle forebrain during anoxia. Brain Research. 625: 181-5. PMID 8275301 DOI: 10.1016/0006-8993(93)91057-Y  0.077
2015 Albin RL. Out of one mutation, many Huntington's disease effects. The Lancet. Neurology. 14: 1071-2. PMID 26466773 DOI: 10.1016/S1474-4422(15)00247-1  0.076
2005 Bomar JM, Benke PJ, Slattery EL, Puttagunta R, Taylor LP, Seong E, Nystuen A, Chen W, Albin RL, Patel PD, Kittles RA, Sheffield VC, Burmeister M. Erratum: Corrigendum: Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse Nature Genetics. 37: 555-555. DOI: 10.1038/Ng0505-555B  0.076
1993 Albin RL. Frontiers in Cognitive Neuroscience Neurology. 43: 1273-1273. DOI: 10.1212/WNL.43.6.1273  0.076
2001 Frey KA, Albin RL. Receptor binding techniques. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit1.4. PMID 18428450 DOI: 10.1002/0471142301.Ns0104S00  0.075
1994 Milbrandt JC, Albin RL, Caspary DM. Age-related decrease in GABAB receptor binding in the Fischer 344 rat inferior colliculus. Neurobiology of Aging. 15: 699-703. PMID 7891824 DOI: 10.1016/0197-4580(94)90051-5  0.075
1992 Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS, Penney JB, Young AB. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46: 35-48. PMID 1317515 DOI: 10.1016/0306-4522(92)90006-N  0.075
1997 Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 919-31. PMID 9307605 DOI: 10.1097/00004647-199709000-00001  0.075
2002 Kearney JA, Buchner DA, De Haan G, Adamska M, Levin SI, Furay AR, Albin RL, Jones JM, Montal M, Stevens MJ, Sprunger LK, Meisler MH. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Human Molecular Genetics. 11: 2765-75. PMID 12374766 DOI: 10.1093/Hmg/11.22.2765  0.075
1998 Carney JF, Chatterjee S, Albin RB. Development of a 100-km/h reusable high-molecular weight/high-density polyethylene truck-mounted attenuator Transportation Research Record. 75-88.  0.075
2001 Kelly KM, Kume A, Albin RL, Macdonald RL. Autoradiography of L-type and N-type calcium channels in aged rat hippocampus, entorhinal cortex, and neocortex. Neurobiology of Aging. 22: 17-23. PMID 11164272 DOI: 10.1016/S0197-4580(00)00178-0  0.075
2006 Albin RL. Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function. Advances in Neurology. 99: 99-106. PMID 16536355  0.075
1993 Price RH, Albin RL, Sakurai SY, Polinsky RJ, Penney JB, Young AB. Cerebellar excitatory and inhibitory amino acid receptors in multiple system atrophy. Neurology. 43: 1323-8. PMID 8392149 DOI: 10.1212/WNL.43.7.1323  0.074
1992 Kincaid AE, Albin RL, Newman SW, Penney JB, Young AB. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscience. 51: 705-18. PMID 1488118 DOI: 10.1016/0306-4522(92)90309-P  0.074
1997 Fink JK, Hedera P, Mathay JG, Albin RL. Paroxysmal dystonic choreoathetosis linked to chromosome 2q: clinical analysis and proposed pathophysiology. Neurology. 49: 177-83. PMID 9222187 DOI: 10.1212/Wnl.49.1.177  0.074
2018 Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Müller MLTM, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [F]-FEOBV. Molecular Psychiatry. PMID 30082840 DOI: 10.1038/S41380-018-0130-5  0.074
2006 Calderhead WJ, Filter KJ, Albin RW. An investigation of incremental effects of interspersing math items on task-related behavior Journal of Behavioral Education. 15: 53-67. DOI: 10.1007/S10864-005-9000-8  0.074
1994 Turgeon SM, Albin RL. GABAB binding sites in early adult and aging rat brain. Neurobiology of Aging. 15: 705-11. PMID 7891825 DOI: 10.1016/0197-4580(94)90052-3  0.074
2013 Piehowski PD, Petyuk VA, Orton DJ, Xie F, Moore RJ, Ramirez-Restrepo M, Engel A, Lieberman AP, Albin RL, Camp DG, Smith RD, Myers AJ. Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. Journal of Proteome Research. 12: 2128-37. PMID 23495885 DOI: 10.1021/Pr301146M  0.074
2013 Silbert L, Dodge H, Lahna D, Giordani B, Koeppe R, Frey K, Burke J, Albin R. Regional white matter lesions and PIB retention in cognitively impaired elderly Alzheimers & Dementia. 9: 27. DOI: 10.1016/J.Jalz.2013.05.036  0.073
1994 Veenman CL, Albin RL, Richfield EK, Reiner A. Distributions of GABAA, GABAB, and benzodiazepine receptors in the forebrain and midbrain of pigeons. The Journal of Comparative Neurology. 344: 161-89. PMID 8077457 DOI: 10.1002/Cne.903440202  0.073
1998 Shankar VN, Albin RB, Milton JC, Mannering FL. Evaluating median crossover likelihoods with clustered accident counts an empirical inquiry using the random effects negative binomial model Transportation Research Record. 44-48. DOI: 10.3141/1635-06  0.072
2000 Kearney JA, Albin RL. Intrasubthalamic nucleus metabotropic glutamate receptor activation: a behavioral, Fos immunohistochemical and [14C]2-deoxyglucose autoradiographic study. Neuroscience. 95: 409-16. PMID 10658620 DOI: 10.1016/S0306-4522(99)00439-X  0.072
1993 Turgeon SM, Albin RL. Pharmacology, distribution, cellular localization, and development of GABAB binding in rodent cerebellum. Neuroscience. 55: 311-23. PMID 8397345 DOI: 10.1016/0306-4522(93)90501-6  0.072
1991 Bazzett TJ, Becker JB, Albin RL. A novel device for chronic intracranial drug delivery via microdialysis. Journal of Neuroscience Methods. 40: 1-8. PMID 1839046 DOI: 10.1016/0165-0270(91)90111-C  0.072
1988 Albin RL. The pleiotropic gene theory of senescence: Supportive evidence from human genetic disease Ethology and Sociobiology. 9: 371-382. DOI: 10.1016/0162-3095(88)90027-1  0.071
1973 Millender LH, Albin RE, Nalebuff EA. Delayed volar advancement flap for thumb tip injuries Plastic and Reconstructive Surgery. 52: 635-639. PMID 4759219  0.071
1994 Kume A, Albin RL. Quantitative autoradiography of 4'-ethynyl-4-n-[2,3-3H2]propylbicycloorthobenzoate binding to the GABAA receptor complex. European Journal of Pharmacology. 263: 163-73. PMID 7821348 DOI: 10.1016/0014-2999(94)90537-1  0.071
2002 Albin RL. Fetal striatal transplantation in Huntington's disease: time for a pause. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 612. PMID 12438457 DOI: 10.1136/jnnp.73.6.612  0.071
2001 Kieburtz K, Penney JB, Corno P, Ranen N, Shoulson I, Feigin A, Abwender D, Greenarnyre JT, Higgins D, Marshall FJ, Goldstein J, Steinberg K, Shih C, Richard I, Hickey C, ... ... Albin R, et al. Unified huntington’s disease rating scale: Reliability and consistency Neurology. 11: 136-142. PMID 8684382 DOI: 10.1002/Mds.870110204  0.071
2003 Bomar JM, Benke PJ, Slattery EL, Puttagunta R, Taylor LP, Seong E, Nystuen A, Chen W, Albin RL, Patel PD, Kittles RA, Sheffield VC, Burmeister M. Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nature Genetics. 35: 264-9. PMID 14556008 DOI: 10.1038/Ng1255  0.071
1995 Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, Sackellares JC, Albin RL. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 45: 934-41. PMID 7746410 DOI: 10.1212/Wnl.45.5.934  0.071
1988 Albin RL, Young AB, Penney JB. Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site. Neuroscience Letters. 88: 303-7. PMID 2838771 DOI: 10.1016/0304-3940(88)90228-5  0.07
1996 Milbrandt JC, Albin RL, Turgeon SM, Caspary DM. GABAA receptor binding in the aging rat inferior colliculus. Neuroscience. 73: 449-58. PMID 8783261 DOI: 10.1016/0306-4522(96)00050-4  0.07
1995 Snyder SE, Kume A, Jung YW, Connor SE, Sherman PS, Albin RL, Wieland DM, Kilbourn MR. Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxides. Journal of Medicinal Chemistry. 38: 2663-71. PMID 7629805 DOI: 10.1021/Jm00014A018  0.069
1994 Kume A, Sakurai SY, Albin RL. Zinc inhibition of t-[3H]butylbicycloorthobenzoate binding to the GABAA receptor complex. Journal of Neurochemistry. 62: 602-7. PMID 8294923 DOI: 10.1046/J.1471-4159.1994.62020602.X  0.069
2021 Albin RL, Kordower JH. Reply to: "Cell Therapy for Huntington's Disease: Learning from Failure". Movement Disorders : Official Journal of the Movement Disorder Society. 36: 788-789. PMID 33749915 DOI: 10.1002/mds.28500  0.069
2012 Zolov SN, Bridges D, Zhang Y, Lee WW, Riehle E, Verma R, Lenk GM, Converso-Baran K, Weide T, Albin RL, Saltiel AR, Meisler MH, Russell MW, Weisman LS. In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proceedings of the National Academy of Sciences of the United States of America. 109: 17472-7. PMID 23047693 DOI: 10.1073/Pnas.1203106109  0.068
1997 Albin RL. The Molecular and Genetic Basis of Neurological Disease Jama: the Journal of the American Medical Association. 278: 599. DOI: 10.1001/jama.1997.03550070091049  0.068
2008 Ray MH, Silvestri C, Conron CE, Albin RB. Assessment of fatality risk in collisions with cable median barriers in the state of Washington Wit Transactions On Information and Communication Technologies. 39: 111-120. DOI: 10.2495/RISK080121  0.067
2008 Albin RL, Joynt RJ. The case of the colorless crystals. Neurology. 70: 1055; author reply 1. PMID 18362289 DOI: 10.1212/01.wnl.0000311259.40672.3c  0.067
1991 Pranzatelli MR, Albin RL, Cohen BH. Acute dyskinesias in young asthmatics treated with theophylline. Pediatric Neurology. 7: 216-9. PMID 1878103 DOI: 10.1016/0887-8994(91)90088-3  0.066
2013 Silbert L, Dodge H, Lahna D, Giordani B, Koeppe R, Frey K, Burke J, Albin R. Regional white matter lesions and Pittsburgh compound B retention in cognitively impaired elderly Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.511  0.066
2010 Perry GM, Tallaksen-Greene S, Kumar A, Heng MY, Kneynsberg A, van Groen T, Detloff PJ, Albin RL, Lesort M. Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease. Human Molecular Genetics. 19: 3354-71. PMID 20558522 DOI: 10.1093/Hmg/Ddq247  0.065
2010 Sheikh NM, Bligh RP, Albin RB, Olson D. Application of precast concrete barrier adjacent to steep roadside slope Transportation Research Record. 121-129. DOI: 10.3141/2195-13  0.065
2006 Albin R. Modern technology as a denaturalizing force Poiesis Und Praxis. 4: 289-302. DOI: 10.1007/s10202-006-0028-1  0.064
1999 Sprunger LK, Escayg A, Tallaksen-Greene S, Albin RL, Meisler MH. Dystonia associated with mutation of the neuronal sodium channel Scn8a and identification of the modifier locus Scnm1 on mouse chromosome 3. Human Molecular Genetics. 8: 471-9. PMID 9949206 DOI: 10.1093/Hmg/8.3.471  0.064
2017 Albin RL. Tourette syndrome: a disorder of the social decision-making network. Brain : a Journal of Neurology. PMID 29053770 DOI: 10.1093/brain/awx204  0.063
2016 Wehner AB, Milen AA, Albin RL, Pierchala BA. The p75 Neurotrophin Receptor Augments Survival Signaling in the Striatum of Pre-Symptomatic Q175(WT/HD) mice. Neuroscience. PMID 26947127 DOI: 10.1016/j.neuroscience.2016.02.069  0.063
2007 Lurie Y, Albin R. Moral dilemmas in business ethics: From decision procedures to edifying perspectives Journal of Business Ethics. 71: 195-207. DOI: 10.1007/s10551-006-9134-1  0.063
1991 Albin RL, Price RH, Sakurai SY, Penney JB, Young AB. Excitatory and inhibitory amino acid binding sites in human dentate nucleus. Brain Research. 560: 350-3. PMID 1760743 DOI: 10.1016/0006-8993(91)91258-3  0.063
1982 Albin RS. Research shows short-term psychiatric hospitalization more effective than long-term in many cases Psychiatric News. 17: 22-23, 27. PMID 10261264  0.062
1999 Albin R, De Campo T. Large-volume liposuction in 181 patients Aesthetic Plastic Surgery. 23: 5-15. PMID 10022931 DOI: 10.1007/s002669900235  0.062
1990 Albin RL, Makowiec RL, Hollingsworth Z, Dure LS, Penney JB, Young AB. Excitatory amino acid binding sites in the periaqueductal gray of the rat. Neuroscience Letters. 118: 112-5. PMID 2175406 DOI: 10.1016/0304-3940(90)90261-7  0.062
1991 Albin RL, Sakurai SY, Makowiec RL, Gilman S. Excitatory and inhibitory amino acid neurotransmitter binding sites in the cerebellar cortex of the pigeon (Columba livia). Journal of Chemical Neuroanatomy. 4: 429-37. PMID 1685884 DOI: 10.1016/0891-0618(91)90023-6  0.062
1990 Makowiec RL, Albin RL, Cha JH, Young AB, Gilman S. Two types of quisqualate receptors are decreased in human olivopontocerebellar atrophy cerebellar cortex. Brain Research. 523: 309-12. PMID 1976026 DOI: 10.1016/0006-8993(90)91504-A  0.061
1989 Albin R. Deflection and load assumptions in box-type furniture manufacture Holz Als Roh- Und Werkstoff: European Journal of Wood and Wood Industries. 47: 7-10. DOI: 10.1007/BF02612342  0.061
1992 Turgeon SM, Albin RL. Zinc modulates GABAB binding in rat brain. Brain Research. 596: 30-4. PMID 1467992 DOI: 10.1016/0006-8993(92)91528-M  0.061
2021 Leventhal DK, Albin RL. Interviewing Mice and the Functions of Striatal Dopamine. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33983666 DOI: 10.1002/mds.28646  0.06
1994 Juiz JM, Albin RL, Helfert RH, Altschuler RA. Distribution of GABAA and GABAB binding sites in the cochlear nucleus of the guinea pig. Brain Research. 639: 193-201. PMID 8205472 DOI: 10.1016/0006-8993(94)91730-2  0.059
2020 Young KZ, Moinuddin O, Khandwala N, Albin RL, Barmada S, Besirli C. Exploring retinal imaging as a novel biomarker of Alzheimer’s disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.044895  0.058
2003 Albin R. Experimental Neurology: Introduction Experimental Neurology. 184. DOI: 10.1016/j.expneurol.2003.08.010  0.058
1997 Bazzett T, Geiger A, Coppola B, Albin R. The neuronal NOS inhibitor L-MIN, but not 7-NINA, reduces neurotoxic effects of chronic intrastriatal administration of quinolinic acid. Brain Research. 775: 229-32. PMID 9439850 DOI: 10.1016/S0006-8993(97)00962-1  0.056
2019 Albin RL. Complementary motivational roles of nigroaccumbens and nigrostriatal dopaminergic pathways. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 45. PMID 30653732 DOI: 10.1002/mds.27504  0.056
1989 Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine The American Journal of Medicine. 87: 664-668. PMID 2686434  0.056
1990 Albin RL, Gilman S. Autoradiographic localization of inhibitory and excitatory amino acid neurotransmitter receptors in human normal and olivopontocerebellar atrophy cerebellar cortex. Brain Research. 522: 37-45. PMID 2171714 DOI: 10.1016/0006-8993(90)91574-Z  0.056
2011 Gilman S, Giordani B, Albin R, Koeppe R, Burke J, Kilbourn M, Frey K. Mild Dementia evaluated with [11C]DTBZ and [11C]PiB positron emission tomography Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.277  0.056
1987 Albin R, Müller M, Scholze H. Investigations on the strength of corner joints in case-type furniture Holz Als Roh- Und Werkstoff: European Journal of Wood and Wood Industries. 45: 171-178. DOI: 10.1007/BF02609607  0.056
1989 Albin RL, Aldridge JW, Young AB, Gilman S. Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Research. 491: 185-8. PMID 2569908 DOI: 10.1016/0006-8993(89)90103-0  0.055
1973 Maier SF, Albin RW, Testa TJ. Failure to learn to escape in rats previously exposed to inescapable shock depends on nature of escape response Journal of Comparative and Physiological Psychology. 85: 581-592.  0.055
1994 Sakurai SY, Kume A, Burdette DE, Albin RL. Quantitative autoradiography of [3H]t-butylbicycloorthobenzoate binding to the gamma-aminobutyric acid receptorA complex. The Journal of Pharmacology and Experimental Therapeutics. 270: 362-70. PMID 8035332  0.054
2019 Bohnen NI, Albin RL. Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon? The Lancet. Neurology. PMID 31678033 DOI: 10.1016/S1474-4422(19)30355-2  0.054
1991 Albin RL, Sakurai SY, Makowiec RL, Higgins DS, Young AB, Penney JB. Excitatory amino acid, GABA(A), and GABA(B) binding sites in human striate cortex. Cerebral Cortex (New York, N.Y. : 1991). 1: 499-509. PMID 1668367 DOI: 10.1093/Cercor/1.6.499  0.054
2007 Albin RL. An advance in molecular imaging of dementias. The Lancet. Neurology. 6: 288-9. PMID 17362826 DOI: 10.1016/S1474-4422(07)70060-1  0.054
1989 Albin RL, Gilman S. Parasagittal zonation of GABA-B receptors in molecular layer of rat cerebellum. European Journal of Pharmacology. 173: 113-4. PMID 2558028 DOI: 10.1016/0014-2999(89)90014-9  0.053
1992 Albin RL, Gilman S. GABAA, GABAB, and benzodiazepine binding sites in the cerebellar cortex of the red-eared turtle (Pseudemys scripta). Brain Research. 595: 164-6. PMID 1334769 DOI: 10.1016/0006-8993(92)91469-U  0.053
1984 Albin R, Silverman PM. Identification of the Escherichia coli K-12 cpxA locus as a single gene: construction and analysis of biologically-active cpxA gene fusions Mgg Molecular &Amp; General Genetics. 197: 272-279. PMID 6097796 DOI: 10.1007/BF00330973  0.053
1998 Albin RL. Fuch's corneal dystrophy in a patient with mitochondrial DNA mutations. Journal of Medical Genetics. 35: 258-9. PMID 9541117 DOI: 10.1136/Jmg.35.3.258  0.051
1996 Shukla S, Albin RW. Effects of extinction alone and extinction plus functional communication training on covariation of problem behaviors Journal of Applied Behavior Analysis. 29: 565-568. PMID 8995836  0.051
2014 Bohnen N, Sarter M, Muller M, Dauer W, Albin R. Author response. Neurology. 82: 1568-9. PMID 24895748 DOI: 10.1212/WNL.0000000000000607  0.051
1993 Kuriyama H, Albin RL, Altschuler RA. Expression of NMDA-receptor mRNA in the rat cochlea. Hearing Research. 69: 215-20. PMID 8226342 DOI: 10.1016/0378-5955(93)90110-M  0.051
1995 Albin RL, Young AB, Penney JB. The functional anatomy of disorders of the basal ganglia. Trends in Neurosciences. 18: 63-4. PMID 7537410 DOI: 10.1016/0166-2236(95)80020-3  0.051
1989 Murray RJ, Smialek JE, Golle M, Albin RJ. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization Chest. 96: 1050-1053. PMID 2805835  0.05
1996 Bazzett TJ, Falik RC, Becker JB, Albin RL. Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum. Brain Research. 718: 228-32. PMID 8773793 DOI: 10.1016/0006-8993(96)00143-6  0.05
1986 Albin R, Weber R, Silverman PM. The Cpx proteins of Escherichia coli K12. Immunologic detection of the chromosomal cpxA gene product Journal of Biological Chemistry. 261: 4698-4705. PMID 3007473  0.05
2020 Marawar R, Wakim N, Albin RL, Dodge H. Seizure occurrence and related mortality in dementia with Lewy bodies. Epilepsy & Behavior : E&B. 111: 107311. PMID 32693380 DOI: 10.1016/j.yebeh.2020.107311  0.049
1974 Millender LH, Nalebuff EA, Albin R, Ream JR, Gordon M. Dorsal tenosynovectomy and tendon transfer in the rheumatoid hand Journal of Bone and Joint Surgery - Series A. 56: 601-610. PMID 4822518  0.049
1988 Albin RL, Young AB. Somatosensory phenomena in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 343-6. PMID 2974928 DOI: 10.1002/mds.870030411  0.049
2000 Albin RL, Kearney JA. Alessandro Agnoli Lecture. Models of basal ganglia dysfunction: predictions and pitfalls. Functional Neurology. 15: 135-46. PMID 11062842  0.048
2003 Alb JG, Cortese JD, Phillips SE, Albin RL, Nagy TR, Hamilton BA, Bankaitis VA. Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. The Journal of Biological Chemistry. 278: 33501-18. PMID 12788952 DOI: 10.1074/Jbc.M303591200  0.048
1986 Majure JA, Albin RE, O'Donnell RS, Arganese TJ. Reconstruction of the infected median sternotomy wound Annals of Thoracic Surgery. 42: 9-12. PMID 3729622  0.048
1995 Kearney JA, Albin RL. Adenosine A2 receptor-mediated modulation of contralateral rotation induced by metabotropic glutamate receptor activation. European Journal of Pharmacology. 287: 115-20. PMID 8749024 DOI: 10.1016/0014-2999(95)00479-3  0.045
1980 Arndt DL, Richardson CR, Albin RC, Sherrod LB. Digestibility of chemically treated cotton plant byproduct and effect on mineral balance, urine volume and pH Journal of Animal Science. 51: 215-223. PMID 7410275  0.045
2017 Pappas SS, Bonifacino J, Danek A, Dauer WT, De M, De Franceschi L, DiPaolo G, Fuller R, Haucke V, Hermann A, Kornmann B, Landwehrmeyer B, Levin J, Neiman AM, Rudnicki DD, ... ... Albin RL, et al. Eighth International Chorea–Acanthocytosis Symposium: Summary of Workshop Discussion and Action Points Tremor and Other Hyperkinetic Movements. 7: 428. DOI: 10.5334/tohm.368  0.045
1986 Ellis CN, Gilbert M, Cohen KA, Albers JW, Ball RD, Albin RL, Silverman A, Voorhees JJ. Increased muscle tone during etretinate therapy. Journal of the American Academy of Dermatology. 14: 907-9. PMID 3711400 DOI: 10.1016/S0190-9622(86)70110-2  0.044
2017 Albin RL, Leventhal DK. Reply to "The Missing, the Short, and the Long: Exploring the borderland between psychiatry and neurology". Annals of Neurology. PMID 28856716 DOI: 10.1002/Ana.25033  0.044
2009 Persad C, Ryan K, Frey K, Albin R, Heidebrink J, Barbas N, Giordani B. P1-103: [11 C]PiB in patients with amnestic and non-amnestic MCI Alzheimer's & Dementia. 5: P204-P204. DOI: 10.1016/J.Jalz.2009.04.108  0.044
1993 Albin RL, Hollingsworth Z, Sakurai SY, Gilman S. Inhibitory and excitatory amino acid neurotransmitter binding sites in cynomolgus monkey (Macaca fascicularis) cervical spinal cord. Brain Research. 604: 354-7. PMID 8096159 DOI: 10.1016/0006-8993(93)90391-Y  0.043
1984 Albin R, Silverman PM. Physical and genetic structure of the glpK-cpxA interval of the Escherichia coli K-12 chromosome Mgg Molecular &Amp; General Genetics. 197: 261-271. PMID 6097795 DOI: 10.1007/BF00330972  0.043
1976 Smith RJ, Albin R. Thenar “h-flap” for fingertip injuries Journal of Trauma - Injury, Infection and Critical Care. 16: 778-781. PMID 792463  0.043
1995 Galasso JM, Bazzett TJ, Becker JB, Albin RL. Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid. Neuroreport. 6: 1505-8. PMID 7579135 DOI: 10.1097/00001756-199507310-00010  0.043
1998 Hinman DD, Sorensen SJ, Momont PA, Albin R, Cole NA. Effect of Yeast Culture on Steer Performance, Apparent Diet Digestibility, and Carcass Measurements When Used in a Barley and Potato Finishing Diet1 Professional Animal Scientist. 14: 173-177. DOI: 10.15232/S1080-7446(15)31819-2  0.043
1989 Albin RJ, Johnston GS. External accumulation of radionuclide in hepatic hydrothorax Clinical Nuclear Medicine. 14: 341-343. PMID 2656040  0.041
1988 Murray RJ, Albin RJ, Mergner W, Criner GJ. Diffuse alveolar hemorrhage temporally related to cocaine smoking Chest. 93: 427-429. PMID 3338316  0.041
2013 Dodge H, Zhau J, Harvey D, Silbert L, Kaye J, Albin R. Baseline or progression? Biomarkers predictive of memory decline Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.113  0.041
1992 Upton J, Albin RE, Mulliken JB, Murray JE. The use of scapular and parascapular flaps for cheek reconstruction. Plastic and Reconstructive Surgery. 90: 959-71. PMID 1448531 DOI: 10.1097/00006534-199212000-00003  0.039
2016 Myers A, Chang R, Petyuk VA, Ramirez-Restrepo M, Beckmann ND, Henrion MY, Zhu K, Wang S, Piehowski PD, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, ... ... Albin RL, et al. O2-06-01: The Human Brainome: Human Brain Genome, Transcriptome, and Proteome Integration Alzheimer's & Dementia. 12: P237-P238. DOI: 10.1016/J.Jalz.2016.06.424  0.039
1973 Albin R, Dowell RT, Zak R, Rabinowitz M. Synthesis and degradation of mitochondrial components in hypertrophied rat heart Biochemical Journal. 136: 629-637. PMID 4360715 DOI: 10.1042/Bj1360629  0.036
1996 Albin RL. Mapping Fate: A Memoir of Family, Risk, and Genetic Research Jama: the Journal of the American Medical Association. 275: 491. DOI: 10.1001/jama.1996.03530300075048  0.035
1979 Albin R. Sheltered employment permits mentally handicapped persons to live like ordinary citizens Readaptation. 41-46.  0.035
1975 Hung TK, Albin MS, Brown TD, Bunegin L, Albin R, Jannetta PJ. Biomechanical responses to open experimental spinal cord injury Surgical Neurology. 4: 271-276. PMID 1162604  0.035
1976 Smith AA, Albin R, Crofford M. Heterogeneity of narcotic receptors Pharmacologist. 18.  0.034
2018 Albin RL. Reply: Social communication in Tourette syndrome: a glimpse at the contribution of the insula and the prefrontal cortex. Brain : a Journal of Neurology. PMID 29846538 DOI: 10.1093/brain/awy144  0.034
2013 Dodge H, Zhau J, Harvey D, Silbert L, Kaye J, Albin R. O1-09-04: Baseline or progression? Biomarkers predictive of memory decline Alzheimer's & Dementia. 9: P146-P147. DOI: 10.1016/j.jalz.2013.04.101  0.034
1969 Leonard DW, Albin R, Lebowitz M. Performance under massed or spaced extinction following different sequences of varied reward training Psychonomic Science. 16: 130-132. DOI: 10.3758/BF03336335  0.033
1971 Maier SF, Zahorik DM, Albin RW. Relative novelty of solid and liquid diet during thiamine deficiency determines development of thiamine-specific hunger Journal of Comparative and Physiological Psychology. 74: 254-262. PMID 5541551 DOI: 10.1037/h0030333  0.033
1970 Aschenbrenner B, Druyan R, Albin R, Rabinowitz M. Haem a, cytochrome c and total protein turnover in mitochondria from rat heart and liver. The Biochemical Journal. 119: 157-60. PMID 5488910 DOI: 10.1042/Bj1190157  0.033
1998 Savoiardo M, Albin RL. Cerebellar input tremor: Inferior or superior cerebellar peduncle lesion? [8] (multiple letters) Neurology. 51: 1777-1778. PMID 9855560  0.033
2015 Cary BP, Brooks AF, Fawaz MV, Shao X, Desmond TJ, Carpenter GM, Sherman P, Quesada CA, Albin RL, Scott PJ. Targeting Metal-Aβ Aggregates with Bifunctional Radioligand [(11)C]L2-b and a Fluorine-18 Analogue [(18)F]FL2-b. Acs Medicinal Chemistry Letters. 6: 112-116. PMID 25705326 DOI: 10.1021/Ml500413D  0.032
1990 Albin RL. The Motor Cortex Neurology. 40: 869-869. DOI: 10.1212/WNL.40.5.869-a  0.032
2020 Albin RL. The killing season: a history of the Indonesian massacres, 1965–1966, by Geoffrey B. Robinson. Princeton, NJ: Princeton University Press, 2018. Pp. xx + 456. Hardcover £30.00, ISBN: 978-0-691-16138-9; paperback £18.99, ISBN: 978-0-691-19649-7. Journal of Global History. 15: 196-199. DOI: 10.1017/s1740022819000433  0.031
1977 Parker HW, Albin RC, Vernor TE, Fahle DW. THERMOCHEMICAL MODIFICATION OF MESQUITE FOR RUMINANT RATIONS . 1: 191-195.  0.03
1981 Albin RS. Art therapy seen as healing, not analytic Psychiatric News. 16: 28. PMID 10252898  0.029
1968 Curl SE, Fennell MA, Zinn DW, Albin RC. Growth and development of the bovine as related to certain endocrine factors Journal of Animal Science. 27: 1011-1014. PMID 5744258  0.028
1971 Cornett CD, Sherrod LB, Albin RC. Effect of methods of processing upon digestibility of a new wheat by sheep and cattle Journal of Animal Science. 32: 716-720. PMID 5571554  0.027
1981 Albin RS. Sociobiology: its implications for the humanities Humanities Report. 3: 4-8. PMID 11650510  0.026
2018 Albin RL. Origin story: a big history of everything By David Christian New York:Little, Brown and Company, 2018. Pp. x + 368. Hardback $30.00, ISBN: 978-0-316-39200-6 Journal of Global History. 13: 497-499. DOI: 10.1017/S1740022818000281  0.026
1990 Albin RL, Young AB, Penney JB. Reply Trends in Neurosciences. 13: 94-95. DOI: 10.1016/0166-2236(90)90183-B  0.026
2019 Albin RL. American Empire: A Global History by A. G. Hopkins, and: The Rise and Fall of the British Nation: A Twentieth-Century History by David Edgerton Journal of World History. 30: 636-642. DOI: 10.1353/jwh.2019.0065  0.026
2017 Albin RL. Polyglutamine inclusion body toxicity. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29119663 DOI: 10.1002/mds.27226  0.025
1975 Albin RC, Sherrod LB. NUTRITIONAL VALUE OF CATTLE FEEDLOT WASTE FOR GROWING - FINISHING BEEF CATTLE . 211-213, 217.  0.025
1991 Albin RL. Brainstem Mechanisms of Behavior Neurology. 41: 161-161. DOI: 10.1212/WNL.41.1.161-c  0.024
1992 Kaatz KW, Bazzett TJ, Albin RL. A new, simple myelin stain. Brain Research Bulletin. 29: 697-8. PMID 1384938 DOI: 10.1016/0361-9230(92)90141-J  0.023
2021 Vicario CM, Gulisano M, Maugeri N, Albin RL, Rizzo R. Moral Decision-Making in Adolescents with Tourette Syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34155689 DOI: 10.1002/mds.28705  0.023
1976 Hui FW, Krikun E, Albin R, Smith AA. Growth retardation by DL methadone in neonatal mice Pharmacologist. 18.  0.023
2005 Albin RL. A new hypothesis for dystonia. Annals of Neurology. 58: 5-6. PMID 15984025 DOI: 10.1002/ana.20520  0.022
1982 Albin RS. Psychiatric help programs for employees on rise Psychiatric News. 17. PMID 10256384  0.022
1968 Leonard DW, Weimer J, Albin R. An examination of Pavlovian induction phenomena in differential instrumental conditioning Psychonomic Science. 12: 89-90. DOI: 10.3758/BF03331207  0.021
1990 Mallon R, Borkowski J, Albin R, Pepitoni S, Schwartz J, Kieff E. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5′ long terminal repeat Journal of Virology. 64: 6282-6285. PMID 2173793 DOI: 10.1128/Jvi.64.12.6282-6285.1990  0.021
1987 Albin RJ, Rubin LJ. Thrombolytic therapy in pulmonary embolism Practical Cardiology. 13: 87-103.  0.02
2018 Albin RL. Against the Grain: A Deep History of the Earliest States by James C. Scott Journal of World History. 29: 571-574. DOI: 10.1353/JWH.2018.0057  0.019
2016 Albin RL. Maurice Simeon Albin. Bmj (Clinical Research Ed.). 354: i3869. PMID 27405307  0.018
2003 Albin RL. Genomic medicine. The New England Journal of Medicine. 349: 2170-1; author reply. PMID 14645650 DOI: 10.1056/Nejm200311273492219  0.018
1972 Aschenbrenner V, Albin R, Zak R, Nair KG, Rabinowitz M. Increased turnover of mitochondrial constituents in cardiac hypertrophy and acute hypoxia in the rat Recent Advances in Studies On Cardiac Structure and Metabolism. 1: 178-185. PMID 4377823  0.018
1983 Pearlman NW, Albin RE, O'Donnell RS. Mandibular reconstruction in irradiated patients utilizing myosseous-cutaneous flaps The American Journal of Surgery. 146: 474-477. PMID 6625091 DOI: 10.1016/0002-9610(83)90234-9  0.017
1974 Albin RJ, Gonder MJ, Soanes WA. Immunohistologic studies of carcinoma of the prostate. III. Elution of interepithelial antibodies from carcinomatous human prostatic tissue following cryoprostatectomy Oncology. 29: 329-334. PMID 4601846  0.016
1974 Albin RK, Weil LS. Flexible implant arthroplasty of the great toe: An evaluation Journal of the American Podiatry Association. 64: 967-975. PMID 4443543  0.016
1980 Frye DF, Albin RE. Skin flap survival in phenytoin treated rats Clinical Research. 28.  0.016
2020 Albin RL. The Little Ice Age and the Demise of Rome: Lessons for the Anthropocene? Journal of World History. 31: 225-232. DOI: 10.1353/jwh.2020.0008  0.016
1981 Albin RR. Edward D. Baker and California’s First Repblican Campaign California History. 60: 280-289. DOI: 10.2307/25158057  0.015
2014 Snider J, Albin RL. Structural causes of chorea Chorea : Causes and Management. 279-294. DOI: 10.1007/978-1-4471-6455-5_16  0.015
1982 Albin RS. Children of psychotic mothers may benefit from home care Psychiatric News. 17. PMID 10262499  0.015
1972 Ueckert DN, Yang SP, Albin RC. Biological value of rangeland grasshoppers as a protein concentrate Journal of Economic Entomology. 65: 1286-1292. PMID 5085787  0.014
2018 Albin RL. Ecology and Power in the Age of Empire: Europe and the Transformation of the Tropical World by Corey Ross Journal of World History. 29: 563-566. DOI: 10.1353/JWH.2018.0055  0.012
1979 Albin RS. Women and science editorials Science. 203: 227-228.  0.011
1971 Albin RC. Handling and disposal of cattle feedlot waste Journal of Animal Science. 32: 803-810. PMID 4937054  0.011
1991 Vogel CM, Albin R, Albers JW. Lotus footdrop: Sciatic neuropathy in the thigh Neurology. 41: 604-606. PMID 2011269 DOI: 10.1212/Wnl.41.4.605  0.011
1966 Albin RC, Clanton DC. Factors contributing to the variation in urinary creatinine and creatinine-nitrogen ratios in beef cattle Journal of Animal Science. 25: 107-112. PMID 5910961  0.01
1994 Rozhon E, Albin R, Schwartz J. Strategies for discovering antiviral agents from natural products Biotechnology (Reading, Mass.). 26: 223-245. PMID 7749304  0.01
2009 Albin RL. The US health care system: Part 1: our current system. Neurology. 73: 571;author reply 571. PMID 19687461 DOI: 10.1212/WNL.0b013e3181af0a3a  0.01
2006 Albin RL, Barbas NR. Preface Clinics in Geriatric Medicine. 22: xi-xii. DOI: 10.1016/j.cger.2006.06.013  0.01
1996 Albin RL. The business of genomics. Nature Genetics. 14: 17. PMID 8782814 DOI: 10.1038/ng0996-17  0.01
1993 Albin RL. Regeneration Neurology. 43: 1274-1274. DOI: 10.1212/WNL.43.6.1274-b  0.01
1972 Albin R, Reyes HM, Replogle RL. A penile testis Journal of Pediatric Surgery. 7: 308-309. PMID 4402615 DOI: 10.1016/0022-3468(72)90131-5  0.01
Hide low-probability matches.